Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $10.82, gaining 10.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...

Timothy Mellon, their heir to the Mellon family’s $14 billion fortune, has quietly emerged as one of Donald Trump’s largest ...

The market was feeling calm on Monday, after a frenetic week where Donald Trump's win in the presidential election helped power stocks to record highs. The Cboe Volatility Index, a widely-followed ...

Started as a trial program two years ago to help boost dismal recruiting numbers, the prep course is fueling the Army’s ...

The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 23.80% higher than today’s ...

At the low target, the stock would reset 50% down from its current value ... But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over. The 24/7 Wall ...

The ripple effects of President-elect Donald Trump’s win are already being felt throughout the U.S. economy as, experts say, ...

“Since earlier in the year, labor market conditions have generally eased, and the unemployment rate has moved up but remains low. Inflation has made progress toward the Committee ... Donald Trump’s ...

Finally, a legitimate shot at an end to the streak without rain, which is now at 37 days and counting. First, a seasonable ...

Upstart stock jumped 40% in morning trading on November 8 after reporting better-than-expected revenue and earnings. Read my ...